1. Home
  2. GIII vs NTLA Comparison

GIII vs NTLA Comparison

Compare GIII & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo G-III Apparel Group LTD.

GIII

G-III Apparel Group LTD.

N/A

Current Price

$30.77

Market Cap

1.4B

ML Signal

N/A

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

N/A

Current Price

$10.22

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIII
NTLA
Founded
1956
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
GIII
NTLA
Price
$30.77
$10.22
Analyst Decision
Buy
Buy
Analyst Count
4
20
Target Price
★ $34.75
$22.78
AVG Volume (30 Days)
330.0K
★ 4.3M
Earning Date
12-08-2026
11-05-2026
Dividend Yield
★ 1.29%
N/A
EPS Growth
N/A
★ 27.43
EPS
★ 1.95
N/A
Revenue
★ $2,957,012,000.00
$67,671,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.17
$174.74
P/E Ratio
$15.94
★ N/A
Revenue Growth
N/A
★ 16.92
52 Week Low
$24.61
$8.09
52 Week High
$37.54
$18.48

Technical Indicators

Market Signals
Indicator
GIII
NTLA
Relative Strength Index (RSI) 50.53 42.91
Support Level $26.69 N/A
Resistance Level $32.80 $13.59
Average True Range (ATR) 1.06 0.78
MACD -0.17 -0.16
Stochastic Oscillator 8.43 34.39

Price Performance

Historical Comparison
GIII
NTLA

About GIII G-III Apparel Group LTD.

G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: